EU Health Innovation Partnership Reflects Medtech’s Role In Unmet Needs
MedTech Europe’s Director Of European Research & Innovation Partnership Policies Explains The Prize At Stake In A Unique Project For Medtechs
You may also be interested in...
The deputy head of the European Medicines Agency has outlined the steps the agency is taking to assess and address the possibility of drug shortages in Europe caused by the coronavirus outbreak, as the number of cases worldwide tops the 98,000 mark.
There can be no such thing as a COVID dividend, but the renewed digital push and momentum for health system change perhaps come closest.
COVID-19 has forced a rethink in how care should be delivered. Healthcomms Consulting partner Dan Jones says it is an opportunity that must not be squandered.